Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Dec 8;14(1):305.
doi: 10.1186/s12957-016-1042-y.

The patterns and timing of recurrence after curative resection for gastric cancer in China

Dan Liu  1 , Ming Lu  1 , Jian Li  1 , Zuyao Yang  2 , Qi Feng  2 , Menglong Zhou  3 , Zhen Zhang  4 , Lin Shen  5
Affiliations

The patterns and timing of recurrence after curative resection for gastric cancer in China

Dan Liu et al. World J Surg Oncol. .

Abstract

Background: The recurrence of gastric cancer after curative resection had adverse effects on patients' survival. The treatment presence varied from different countries. The aims of this study were to understand the recurrence incidence, patterns, and timing and to explore the risk factors in China.

Methods: One thousand three hundred four patients who undergoing curative resection from more than 100 hospitals between January 1st 1986 and September 1st 2013, were surveyed in detail. Clinical pathological factors were examined as potential risk factors of each recurrence pattern using univariate and multivariate analyses. Recurrence timing was also analyzed based on disease-free survival.

Results: Among 1304 gastric cancer patients, 793 patients (60.8%) experienced recurrence and 554 patients (42.5%) experienced recurrence within 2 years after operation. The median disease-free survival was 29.00 months (interquartile range [IQR] 12.07, 147.23). Receiving operation in general hospitals was one of independent risk factors of local-regional recurrence (OR = 1.724, 95% CI 1.312 to 2.265) and distant metastasis (OR = 1.496, 95% CI 1.164 to 1.940). Patients would suffer lower risk of distant metastasis if they received no more than 3 cycles adjuvant chemotherapy (OR = 0.640, 95% CI 0.433 to 0.943). Adjuvant radiotherapy could reduce the risk of recurrence (OR 0.259, 95% CI 0.100 to 0.670), especially distant metastasis (OR = 0.260, 95% CI 0.083 to 0.816).

Conclusions: More than 60% patients experienced recurrence after curative resection for gastric cancer, especially within 2 years after surgery. Risk factors were clarified between various recurrence patterns. Advanced gastric cancer and undergoing operation in general hospitals contributed to increased recurrence risk and worse survival. Enough number of lymph nodes harvest and standard D2 lymphadenectomy could reduce recurrence. Chinese patients would benefit from adjuvant chemotherapy and radiotherapy.

Keywords: Curative resection; Disease-free survival; Gastric cancer; Overall survival; Postoperative recurrence.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
The screening progress for analysis patients
Fig. 2
Fig. 2
The recurrence patterns of patients with curative gastrectomy
Fig. 3
Fig. 3
a The survival curves for RFS of different recurrence patterns. b The survival curves for OS of different recurrence patterns. c The survival curves for RFS of different surgical hospitals. d The survival curves for RFS of different T status
See this image and copyright information in PMC

References

    1. Torre LA, Freddie B, Rebecca L, et al. Global cancer statistics. CA Cancer J Clin. 2015;65:87–108. doi: 10.3322/caac.21262. - DOI - PubMed
    1. Chen W, Zheng R, Zhang S, et al. Report of cancer incidence and mortality in China, 2010. Annals of Translational Medicine, 2014, 2(7):61-61 - PMC - PubMed
    1. Spolverato G, Ejaz A, Kim Y, et al. Rates and patterns of recurrence after curative internt resection for gastric cancer: a United States multi-institutional analysis. J Am Coll Surg. 2014;219(4):664–75. doi: 10.1016/j.jamcollsurg.2014.03.062. - DOI - PubMed
    1. Macdonald JS, Smalley SR, Benedetti J, et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med. 2001;345:725–30. doi: 10.1056/NEJMoa010187. - DOI - PubMed
    1. Smalley SR, Benedetti JK, Haller DG, et al. Updated analysis of SWOG-directed intergroup study 0116: a phase III trial of adjuvant radiochemotherapy versus observation after curative gastric cancer resection. J Clin Oncol. 2012;30:2327–2333. doi: 10.1200/JCO.2011.36.7136. - DOI - PMC - PubMed

MeSH terms